7619655

Bragagni G

1995

[43 cases of primary empty sella syndrome: a case series].

7621099

Bertoli A

1995

Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.

7621565

White D

1995

Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.

7623362

Lanzone A

1995

Polycystic ovary disease. A risk factor for gestational diabetes?

7626505

Botwood N

1995

Sex hormone-binding globulin and female reproductive function.

7627285

Ardaens Y

1995

[Polycystic ovaries: an imprecise ultrasonographic definition].

7628088

Mitchell R

1995

Immunometric assays of luteinizing hormone (LH): differences in recognition of plasma LH by anti-intact and beta-subunit-specific antibodies in various physiological and pathophysiological situations.

7629374

Popovic V

1995

The effect of sodium valproate on luteinizing hormone secretion in women with polycystic ovary disease.

7629766

Balen AH

1995

Hypersecretion of luteinizing hormone in the polycystic ovary syndrome and a novel hormone 'gonadotrophin surge attenuating factor'.

7630516

De Vita V

1995

[Bromocryptin + gonadotropin vs. goserelin + gonadotropin in ovulation induction in patients with polycystic ovaries].

7631668

Fukaya T

1995

Laser vaporization of the ovarian surface in polycystic ovary disease results in reduced ovarian hyperstimulation and improved pregnancy rates.

7634500

Lee PJ

1995

The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism.

7634505

Piaditis GP

1995

Dysfunction of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome.

7635975

Dunaif A

1995

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

7638120

Emperauger B

1995

[Polycystic ovarian dystrophies. Diagnostic criteria and treatment].

7641911

Ashkenazi J

1995

Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient.

7645685

P?rez Guti?rrez JF

1995

[Regulatory factors of the ovarian function].

7647052

Hull M

1995

Complications of pregnancy after infertility treatment: awareness and prevention.

7647273

Jacobs HS

1995

Polycystic ovary syndrome: aetiology and management.

7647276

Homburg R

1995

Growth hormone and reproduction.

7647277

Morris D

1995

The etiology of hyperandrogenism in women.

7650129

Fauser BC

1995

Genetic basis of human reproductive endocrine disorders.

7650311

Colombo PL

1995

[Use of a gonadoliberin agonist with or without gonadoliberin pulses for ovulation induction in ovarian dystrophies].

7651477

Franks S

1995

Polycystic ovary syndrome.

7657740

Cheung AP

1995

Pituitary responsiveness to gonadotrophin-releasing hormone agonist stimulation: a dose-response comparison of luteinizing hormone/follicle-stimulating hormone secretion in women with polycystic ovary syndrome and normal women.

7660719

Falsetti L

1994

Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism.

7662572

Panidis D

1995

Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome.

7671095

Lobo RA

1995

Polycystic ovary syndrome/hyperandrogenic chronic anovulation.

7671097

Mantzoros CS

1995

Insulin resistance: the clinical spectrum.

7671850

Ehrmann DA

1995

Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

7672136

Brzyski RG

1995

Increase in androgen:estrogen ratio specifically during low-dose follicle-stimulating hormone therapy for polycystic ovary syndrome.

7672138

Fulghesu AM

1995

Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease.

7672144

Duffy DM

1995

Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.

7673399

Holte J

1995

Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.

7675372

Douchi T

1995

Body fat distribution in women with polycystic ovary syndrome.

7682564

Insler V

1993

Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings.

7684393

Mason HD

1993

Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries.

7685718

Tiitinen AE

1993

Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease.

7686730

Laatikainen T

1993

How IGF-I and IGF-I binding protein can be modulated in polycystic ovarian syndrome.

7690311

Tiitinen A

1993

Ovarian electrocauterization causes LH-regulated but not insulin-regulated endocrine changes.

7693380

Hamilton-Fairley D

1993

Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction.

7695722

Blumenfeld Z

1994

Long live the small difference.

7704095

Takagi T

1994

Changes in serum immunoreactive inhibin during ovulation induction in women with amenorrhea.

7704720

Dunaif A

1994

Polycystic ovary syndrome.

7704755

Peillon F

1994

Functional hyperprolactinemia.

7704957

Bridges NA

1995

Ovaries in sexual precocity.

7709690

Tolino A

1994

Obesity and reproduction.

7709764

Miller JE

1994

Characterization of 24-h cortisol release in obese and non-obese hyperandrogenic women.

7711208

Luza SM

1995

Hypothalamic changes in norepinephrine release in rats with estradiol valerate-induced polycystic ovaries.

7714138

Lanzone A

1994

Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome.

7714140

Takahashi K

1994

Relationship between ultrasonography and histopathological changes in polycystic ovarian syndrome.

7714155

Naether OG

1994

Long-term follow-up in 206 infertility patients with polycystic ovarian syndrome after laparoscopic electrocautery of the ovarian surface.

7715508

Hulinsky I

1995

External jugular vein thrombosis: a complication of the ovarian hyperstimulation syndrome.

7720247

Luppa P

1995

6 alpha-biotinylated estrone: novel tracer in competitive chemiluminescence immunoassay of estrone in serum.

7720907

Jaatinen TA

1995

Serum total renin is elevated in women with polycystic ovarian syndrome.

7720939

Ben-Shlomo I

1995

The polycystic ovary syndrome: nature or nurture?

7720944

Suganuma N

1995

Screening of the mutations in luteinizing hormone beta-subunit in patients with menstrual disorders.

7723677

Diamanti-Kandarakis E

1995

Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome.

7725507

Cogny-Van Weydevelt F

1995

Graft of a trophoblastic neoplasia by a kidney transplant.

7725637

Kreze A Jr

1995

[Hyperandrogenic states in women (polycystic ovary syndrome) and insulin resistance].

7725646

Hrnciar J

1995

[Clinical manifestations of the insulin resistance syndrome. The hormonal-metabolic syndrome X, the 5H syndrome and their etiopathogenesis].

7727967

Urdl W

1995

[Pathogenesis and diagnosis of polycystic ovary syndrome].

7727977

Hartmann BW

1995

[Current therapy of polycystic ovary].

7729720

Jakowicki J

1994

[Insulin resistance in the pathogenesis of polycystic ovarian disease (PCOD)].

7742501

Honor? LH

1994

Pathology of female infertility.

7745065

Prelevic GM

1995

The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries.

7745074

Nahum R

1995

Metabolic regulation of androgen production by human thecal cells in vitro.

7745077

Farhi J

1995

In-vitro cervical mucus-sperm penetration tests and outcome of infertility treatments in couples with repeatedly negative post-coital tests.

7750581

Lobo RA

1995

A disorder without identity: HCA, PCO, PCOD, PCOS, SLS. what are we to call it?!

7750588

Lanzone A

1995

Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome.

7750589

B?tzow TL

1995

Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome.

7750613

Pryor RA

1995

Adnexal infarction after conservative surgical management of torsion of a hyperstimulated ovary.

7752909

Andersen P

1995

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

7757724

Kitaoka Y

1993

[Polycystic ovary syndrome (PCOS)].

7762740

Khe?fets SN

1995

[Diagnosis of hyperandrogenic state in women].

7770269

Carmina E

1995

Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome.

7782424

Suikkari AM

1995

Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.

7789918

Takahashi K

1995

Transvaginal ultrasonographic morphology in polycystic ovarian syndrome.

7791504

Kaaijk EM

1995

Laparoscopic surgery of chronic hyperandrogenic anovulation.

7793298

S?tterlin M

1995

Sensitivity of plasma insulin levels in obese and non-obese women with functional hyperandrogenism.

7793299

dos Reis RM

1995

Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism.

7803980

Mor?n C

1994

Etiological review of hirsutism in 250 patients.

7803981

Mor?n C

1994

Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.

7804379

Dewailly D

1994

[Does the endocrinal milieu influence the expression and/or the action of ovarian growth factors in polycystic ovary syndrome?].

7805925

Norman RJ

1995

Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome.

7813604

Fitko R

1994

Ovarian LH/hCG receptors and plasma level of LH,17-beta estradiol and progesterone in gonadotropin--induced PCO syndrome in rats.

7814930

Ohkura T

1994

[Efficacy and endocrinological analysis of combined buserelin-pure FSH-hCG therapy in patients with polycystic ovary syndrome].

7815426

Kuznetzova T

1994

X;Y translocation in a girl with short stature and some features of Turner's syndrome: cytogenetic and molecular studies.

7825632

Redmond GP

1995

Androgenic disorders of women: diagnostic and therapeutic decision making.

7825633

Burkman RT Jr

1995

The role of oral contraceptives in the treatment of hyperandrogenic disorders.

7825634

Derman RJ

1995

Effects of sex steroids on women's health: implications for practitioners.

7825638

Wild RA

1995

Obesity, lipids, cardiovascular risk, and androgen excess.

7825639

Dunaif A

1995

Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.

7825641

Giudice LC

1995

The insulin-like growth factor system in normal and abnormal human ovarian follicle development.

7825642

Gibson M

1995

Reproductive health and polycystic ovary syndrome.

7825645

Lucky AW

1995

Hormonal correlates of acne and hirsutism.

7825646

Legro RS

1995

The genetics of polycystic ovary syndrome.

7828341

Kyei-Mensah A

1994

Ovarian stromal hypertrophy.

7828342

Dewailly D

1994

Ovarian stromal hypertrophy in hyperandrogenic women.

7829627

Luppa P

1995

Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion.